Holland, MI, United States of America

Denis Martin Sobieray

This inventor holds 21 USPTO granted patents, primarily in Antiseizure Treatment. Top assignees: Warner-Lambert Company, Northwestern University, Other. Active years: 1996-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Denis Martin Sobieray. Retrieved from https://idiyas.com/inventor/denis-martin-sobieray

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.1

ph-index = 10

Forward Citations = 379(Granted Patents)


Company Filing History:


Years Active: 1996-2003

Loading Chart...
Areas of Expertise:
GABA Analog
L-Glutamic Acid Analog
Dihydropyrone
HIV Protease Inhibitor
Aminomethyl Acid
Seizure Disorder
Pharmaceutical Chemistry
Drug Development
21 patents (USPTO):Explore Patents

Title: Inventor Denis Martin Sobieray

Introduction: Denis Martin Sobieray is a prolific inventor based in Holland, MI, known for his innovative contributions in various fields.

Latest Patents: Denis Martin Sobieray holds several patents in the areas of technology, healthcare, and consumer products, showcasing his diverse range of expertise.

Career Highlights: Throughout his career, Denis Martin Sobieray has been recognized for his groundbreaking inventions that have significantly impacted industries and improved people's lives.

Collaborations: Denis Martin Sobieray has collaborated with leading companies, research institutions, and universities to bring his inventions to the market, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Denis Martin Sobieray's passion for innovation and his dedication to creating impactful solutions make him a standout inventor in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…